PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 13, 2026British Journal of Biomedical Science0 citationsOpen Access

Matrix metalloproteinase activation and TNF upregulation characterize the sclerotic phase of aortic valve disease

ECElizabeth Chan-DelgadoCLClaudia LermaJEJuan C. Echeverría

Key Result

Aortic valve sclerosis was independently associated with a higher MMP-9/TIMP-1 ratio (β 0.78) compared to normal aortic valves, indicating an active proteolytic and inflammatory profile.

Study Design

Type

Cross-Sectional (n=168)

Multicenter

No

Structured PICO

P
Population
168 participants including 29 with normal aortic valve (NAV), 98 with aortic valve sclerosis (AVSc), and 41 with aortic stenosis (AS)
O
Outcome
Serum levels of matrix metalloproteinase (MMP)-1, -2, -3, and -9, tissue inhibitor of metalloproteinases-1 (TIMP-1), tumor necrosis factor (TNF), interleukin-6 (IL-6), and transforming growth factor-beta (TGF-β)surrogate

Aortic valve sclerosis is characterized by an active proteolytic and inflammatory biomarker profile, specifically elevated MMP-9 and TNF with reduced TIMP-1, distinguishing it from normal valves and aortic stenosis.

Main Result

Effect estimate: β 0.78 (95% CI 0.52-1.04)

Absolute Event Rate: 11% vs 4.8%

p-value: p=<0.001

Limitations

  • Cross-sectional design precludes causal inference or assessment of progression from sclerosis to stenosis.
  • Patients with AS were older and had more comorbidities, complicating direct comparisons.
  • Quantified circulating biomarkers may not fully represent local valvular processes.

Abstract

Introduction Aortic valve sclerosis (AVSc) is an active pathological process driven by extracellular matrix remodeling, consistent with a potentially reversible early stage of aortic valve disease. Methods In this cross-sectional study of 168 participants (29, normal aortic valve NAV; 98, AVSc; 41, aortic stenosis AS), serum levels of matrix metalloproteinase (MMP)-1, -2, -3, and -9, tissue inhibitor of metalloproteinases-1 (TIMP-1), tumor necrosis factor (TNF), interleukin-6 (IL-6), and transforming growth factor-beta (TGF-β) were measured. Multivariable adjustments were performed. Results Compared with AS, AVSc was associated with higher circulating MMP-9 levels, with MMP-9 also increased relative to NAV. TIMP-1 concentrations were reduced in AVSc compared with both AS and NAV. TNF levels were higher in AVSc than in AS, while IL-6 and TGF-β did not differ among groups. Notably, MMP-9/TIMP-1 ratio was markedly increased in AVSc. Discussion Our findings suggest that AVSc may exhibit an active proteolytic and inflammatory profile amenable to targeted anti-inflammatory and anti-proteolytic interventions.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Chan-Delgado et al. (2026) conducted a cross-sectional in Aortic valve sclerosis (n=168). Aortic valve sclerosis (AVSc) vs. Normal aortic valve (NAV) was evaluated on Log (MMP-9/TIMP-1) ratio (β 0.78, 95% CI 0.52-1.04, p=<0.001). Aortic valve sclerosis was independently associated with a higher MMP-9/TIMP-1 ratio (β 0.78) compared to normal aortic valves, indicating an active proteolytic and inflammatory profile.

synapsesocial.com/papers/6a0e4efe28562748820786dbhttps://doi.org/10.3389/bjbs.2026.16540
Ask AI
Helpful
Bookmark
Share
View Full Paper